Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)—Readdressing the DReSS

Late sequelae of drug reaction with eosinophilia and systemic symptoms (DRESS) cause thyroid dysfunction and thyroiditis: review of literature

(2022) Therdpong Tempark et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

“Heart in DRESS”: Cardiac Manifestations, Treatment and Outcome of Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Systematic Review

(2022) Milan Radovanovic et al.   Journal of Clinical Medicine

Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS)

(2021) Fumi Miyagawa et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases

(2021) C. Brin et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: Facial edema aligns to the severe phenotype

(2021) Sophie Elizabeth Momen et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Clinical, biochemical and serological predictors of DRESS syndrome: a prospective case-control study

(2021) Rajat Choudhary et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case Series

(2021) Angèle Soria et al.   Journal of Allergy and Clinical Immunology-In Practice

Immunopharmacogenomics: Mechanisms of HLA‐Associated Drug Reactions

(2021) Pooja Deshpande et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases

(2021) Eve Bedouelle et al.   Journal of Allergy and Clinical Immunology-In Practice

Updates and Insights in the Diagnosis and Management of DRESS Syndrome

(2021) Elisa Maria Schunkert et al.   Current Dermatology Reports

Spanish Guidelines for Diagnosis, Management, Treatment and Prevention of DRESS syndrome

(2020) R Cabañas et al.   JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY

A case of drug reaction with eosinophilia and systemic symptoms (DRESS) without a typical precipitant

(2020) David WJ Griffin et al.   MEDICAL JOURNAL OF AUSTRALIA

Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report

(2020) Doyoung Kim et al.   NATURE MEDICINE

Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children

(2020) Wiparat Manuyakorn et al.   EPILEPSY RESEARCH

Influence of corticosteroid therapy on viral reactivation in drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms

(2020) Mikiko Tohyama et al.   JOURNAL OF DERMATOLOGY

Assessment of Outcomes With Pulsed Dye Laser Treatment of Port-Wine Stains Located Proximally vs Distally on Extremities

(2020) Wenxin Yu et al.   JAMA Dermatology

Monitoring of human herpesvirus 6 infection in the management of drug reaction with eosinophilia and systemic symptoms

(2020) V. Descamps et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review

(2020) Shiva Sharifzadeh et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

DRESS syndrome following furosemide administration: An unusual association

(2020) N. Ben Fadhel et al.   Nephrologie & Therapeutique

Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS)

(2020) Lukas Jörg et al.   Clinical and Translational Allergy

Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come?

(2019) Sylvia Aide Martínez-Cabriales et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study

(2019) Karam Mounzer et al.   AIDS Research and Therapy

Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome

(2019) Sylvia A Martinez-Cabriales et al.   World Journal of Clinical Cases

HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms

(2019) Katherine C. Konvinse et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Virus-specific T cell clonotypes may contribute to drug hypersensitivity reactions via heterologous immunity

(2019) Coral-Ann Almeida et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019

(2019) Tetsuo Shiohara et al.   ALLERGOLOGY INTERNATIONAL

HLA-B*58:01 Genotyping to Prevent Cases of DRESS and SJS/TEN in East Asians Treated with Allopurinol—A Canadian Missed Opportunity

(2019) Marisa Grace Ponzo et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Drug reaction with eosinophilia and systemic symptoms (DRESS) may occur within two weeks of drug exposure: a retrospective study

(2019) Angèle Soria et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review

(2019) Pahnwat Tonya Taweesedt et al.   Biomed Research International

Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature

(2019) Lauren Metterle et al.   PEDIATRIC DERMATOLOGY

Co-Occurrence of Multiple Endocrine Abnormalities Induced by the DIHS/DRESS

(2019) Mingqun Deng et al.   International Journal of Endocrinology

Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment

(2018) R. Cabañas et al.   CLINICAL AND EXPERIMENTAL ALLERGY

The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions

(2018) Wei-Ti Chen et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions

(2018) Wimonchat Tangamornsuksan et al.   JAMA Dermatology

An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity

(2018) Chun-Bing Chen et al.   Journal of Immunology Research

Antituberculosis Drug-Associated DRESS: A Case Series

(2018) Marion Allouchery et al.   Journal of Allergy and Clinical Immunology-In Practice

Restoring Self-tolerance in Autoimmune Diseases by Enhancing Regulatory T-cells

(2018) Prabhakaran Kumar et al.   CELLULAR IMMUNOLOGY

Predictors of disease severity in drug reaction with eosinophilia and systemic symptoms

(2018) Sarita Sasidharanpillai et al.   Indian Journal of Dermatology Venereology & Leprology

Prevalence, risk factors, and mortality outcome in the drug reaction with eosinophilia and systemic symptoms patients with cardiac involvement

(2018) Julphat Intarasupht et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease

(2018) Yoshiko Mizukawa et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module

(2018) Anna R. Wolfson et al.   Journal of Allergy and Clinical Immunology-In Practice

Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS)

(2017) Tetsuo Shiohara et al.   Expert Opinion on Drug Metabolism & Toxicology

Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13

(2017) Therdpong Tempark et al.   Pharmacogenetics and Genomics

Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population

(2017) Elena Ramírez et al.   PHARMACOLOGICAL RESEARCH

Human Herpesvirus 6 Reactivation in DRESS With Acute Liver Failure

(2017) Vincent Descamps et al.   TRANSPLANTATION

Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms

(2017) Philippe Ichai et al.   TRANSPLANTATION

HLA B62 as a possible risk factor for drug reaction with eosinophilia and systemic symptoms to piperacillin/tazobactam

(2017) Krzysztof Rutkowski et al.   Journal of Allergy and Clinical Immunology-In Practice

Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: An immunohistochemical study

(2017) Katharina Hansel et al.   Journal of Allergy and Clinical Immunology-In Practice

Virus Reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms (Dress) Results from a Strong Drug-Specific Immune Response

(2017) Jean-Claude Roujeau et al.   Journal of Allergy and Clinical Immunology-In Practice

In vitrotests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper

(2016) C. Mayorga et al.   ALLERGY

Histopathology of the Exanthema in DRESS Is Not Specific but May Indicate Severity of Systemic Involvement

(2016) Margarida M. Gonçalo et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Cardiac involvement in DRESS syndrome

(2016)   ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY

Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital

(2016) Elena Ramírez et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward

(2016) M. Pinto Gouveia et al.   BRITISH JOURNAL OF DERMATOLOGY

Evaluation of Lymphocyte Transformation Test Results in Patients with Delayed Hypersensitivity Reactions following the Use of Anticonvulsant Drugs

(2016) Zahra Karami et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression

(2016) Marie Weinborn et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Impact of the HLA-B * 58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions

(2016) Chau Yee Ng et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Comparative histological analysis of drug-induced maculopapular exanthema and DRESS

(2016) F. Skowron et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Management of Psychotropic Drug–Induced DRESS Syndrome: A Systematic Review

(2016) Tanner J. Bommersbach et al.   MAYO CLINIC PROCEEDINGS

Drug Reaction with Eosinophilia and Systemic Symptoms or Virus Reactivation with Eosinophilia and Systemic Symptoms

(2016) Vincent Descamps et al.   PEDIATRIC DERMATOLOGY

Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population

(2016) C-C Chang et al.   PHARMACOGENOMICS JOURNAL

Cyclosporine Treatment of Drug-Induced Hypersensitivity Syndrome

(2016) Mark G. Kirchhof et al.   JAMA Dermatology

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand

(2016) Akarin Hiransuthikul et al.   ALLERGOLOGY INTERNATIONAL

HLA-B*58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand

(2016) Chonlaphat Sukasem et al.   Frontiers in Pharmacology

Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study

(2015) N. Ortonne et al.   BRITISH JOURNAL OF DERMATOLOGY

Hypereosinophilic Syndrome

(2015) Casey Curtis et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Liver injury in patients with DRESS: A clinical study of 72 cases

(2015) I-Chun Lin et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Acute generalized exanthematous pustulosis (AGEP): A review and update

(2015) Jesse Szatkowski et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Therapeutic management of DRESS: A retrospective study of 38 cases

(2015) Elisa Funck-Brentano et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

A fatal case of DRESS induced by strontium ranelate associated with HHV-7 reactivation

(2015) F. Drago et al.   OSTEOPOROSIS INTERNATIONAL

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study

(2015) Tai-Ming Ko et al.   BMJ-British Medical Journal

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study

(2015) Tai-Ming Ko et al.   BMJ-British Medical Journal

HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity

(2014) Niamh M. Keane et al.   AIDS

Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin

(2014) Wen-Hung Chung et al.   ANNALS OF THE RHEUMATIC DISEASES

Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)

(2014) K. Ogawa et al.   BRITISH JOURNAL OF DERMATOLOGY

Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions

(2014) Ursula Amstutz et al.   EPILEPSIA

Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions

(2014) Wen-Hung Chung et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

HLA-B*13:01is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population

(2014) Fanping Yang et al.   PHARMACOGENOMICS

Skin tests may induce DRESS relapse

(2014) Benoit Said et al.   Clinical and Translational Allergy

Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study

(2013) S.H. Kardaun et al.   BRITISH JOURNAL OF DERMATOLOGY

Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS)

(2013) M.-H. Chi et al.   BRITISH JOURNAL OF DERMATOLOGY

Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population

(2013) Daniel F. Carr et al.   CLINICAL INFECTIOUS DISEASES

DRESS syndrome

(2013) Zain Husain et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome

(2013) F.-R. Zhang et al.   NEW ENGLAND JOURNAL OF MEDICINE

HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis

(2013) E Genin et al.   PHARMACOGENOMICS JOURNAL

Cutaneous Drug Reactions in Children: An Update

(2013) Kara Heelan et al.   PEDIATRIC DRUGS

Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong

(2012) M.L.S. Chiu et al.   BRITISH JOURNAL OF DERMATOLOGY

A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions

(2012) A. Barbaud et al.   BRITISH JOURNAL OF DERMATOLOGY

Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases

(2012) S. Walsh et al.   BRITISH JOURNAL OF DERMATOLOGY

Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS)

(2012) Kohei Ogawa et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan

(2012) Yi-Chun Chen et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution

(2012) Yukiko Ushigome et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids

(2012) H. Uhara et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?

(2012) Sophie Bouvresse et al.   Orphanet Journal of Rare Diseases

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

(2011) Jing Yuan et al.   AIDS

HLA-Dependent Hypersensitivity Reaction to Nevirapine in Chinese Han HIV-Infected Patients

(2011) Shicheng Gao et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

The DRESS Syndrome: A Literature Review

(2011) Patrice Cacoub et al.   AMERICAN JOURNAL OF MEDICINE

Poor Benefit/Risk Balance of Intravenous Immunoglobulins in DRESS

(2011) P. Joly et al.   ARCHIVES OF DERMATOLOGY

Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans

(2011) Sae-Hoon Kim et al.   EPILEPSY RESEARCH

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans

(2011) Mark McCormack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans

(2011) Hye-Ryun Kang et al.   Pharmacogenetics and Genomics

Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS)

(2010) V. Descamps et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Drug Reaction With Eosinophilia and Systemic Symptoms

(2010) Yi-Chun Chen et al.   ARCHIVES OF DERMATOLOGY

Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking

(2010) S. A. Walsh et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

(2010) Takeshi Ozeki et al.   HUMAN MOLECULAR GENETICS

Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients

(2010) Mariko KASHIWAGI et al.   JOURNAL OF DERMATOLOGY

Visceral Involvements and Long-term Sequelae in Drug-induced Hypersensitivity Syndrome

(2010) Yoko Kano et al.   MEDICAL CLINICS OF NORTH AMERICA

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell Response

(2010) D. Picard et al.   Science Translational Medicine

Recognition of Immune Reconstitution Syndrome Necessary for Better Management of Patients with Severe Drug Eruptions and Those under Immunosuppressive Therapy

(2010) Tetsuo Shiohara et al.   ALLERGOLOGY INTERNATIONAL

Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms

(2009) Majed Eshki et al.   ARCHIVES OF DERMATOLOGY

Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations

(2009) Y. Teraki et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Defective Regulatory T Cells In Patients with Severe Drug Eruptions: Timing of the Dysfunction Is Associated with the Pathological Phenotype and Outcome

(2009) R. Takahashi et al.   JOURNAL OF IMMUNOLOGY

A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis

(2009) J.-F. Augusto et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients

(2009) Soranun Chantarangsu et al.   Pharmacogenetics and Genomics

HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients

(2009) Sirirat Likanonsakul et al.   AIDS Research and Therapy

High Sensitivity of Human Leukocyte Antigen–B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients

(2008) Michael Saag et al.   CLINICAL INFECTIOUS DISEASES